Status | Study |
Completed |
Study Name: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Condition: Chemotherapeutic Agent Toxicity Colorectal Cancer Neuropat Date: 2010-04-06 Interventions: Drug: calcium gluconate Given |
Completed |
Study Name: Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin Condition: Chemotherapeutic Agent Toxicity Colorectal Cancer Date: 2009-04-18 Interventions: Drug: FOLFOX regimen Drug: fluorouracil |
Completed |
Study Name: Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity Condition: Neurotoxic Disorders Cancer Date: 2008-07-31 Interventions: Drug: Mangafodipir Mangafodipir (0.5 ml/kg) is administered as a 30 minutes infusion just after each adm |
Terminated |
Study Name: Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors Condition: Primary Central Nervous System Lymphoma (PCNSL) Date: 2008-07-02 |
Withdrawn |
Study Name: Scopolamine Treatment for Patients With Organophosphate Poisoning Condition: Neurotoxicity Syndromes Date: 2006-10-17 Interventions: Drug: Placebo IV placebo q4h |
Completed |
Study Name: Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer Condition: Neurotoxicity Unspecified Adult Solid Tumor, Protocol Specific Date: 2006-08-10 Interventions: Dietary Supplement: vitamin E |
Completed |
Study Name: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery Condition: Colorectal Cancer Neurotoxicity Date: 2006-04-19 Interventions: Drug: calcium gluconate Given |
Completed |
Study Name: Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors Condition: Neurotoxicity Unspecified Adult Solid Tumor, Protocol Specific Date: 2006-03-21 Interventions: Procedure: management of therapy complications Patients will complete three self-reported questionnaires |
Completed |
Study Name: Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. Condition: Metastases Colorectal Neoplasms Colorectal Carcinoma Date: 2006-03-20 Interventions: Drug: Xaliproden (SR57746A) or |
Completed |
Study Name: Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer Condition: Neurotoxicity Unspecified Adult Solid Tumor, Protocol Specific Date: 2006-01-24 Interventions: Procedure: management of therapy complications Patients undergo a 1-hour peripheral nerve function asses |